KalVista Pharmaceuticals Inc (KALV): Next-Year EPS Estimate 170.01%
As of 2026-06-04, KalVista Pharmaceuticals Inc (KALV) has a next-year EPS growth estimate of 170.01%.
On 2026-05-17, analyst consensus for KALV's next-year EPS growth shifted from 170.20% to 170.01% — a negative change of 0.19 percentage points. The revised estimate has been sustained across 15 subsequent trading sessions. Current-year growth is projected at 57.08%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 170.01%
- EPS growth this year
- 57.08%
- EPS next quarter (est)
- N/A
- Last price
- $26.95
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 170.01% | 57.08% | N/A | $26.95 |
| 2026-06-03 | 170.01% | 57.08% | N/A | $26.95 |
| 2026-06-02 | 170.01% | 57.08% | N/A | $26.94 |
| 2026-06-01 | 170.01% | 57.08% | N/A | $26.94 |
| 2026-05-31 | 170.01% | 57.08% | N/A | $26.87 |
| 2026-05-28 | 170.01% | 57.08% | N/A | $26.77 |
| 2026-05-27 | 170.01% | 57.08% | N/A | $26.79 |
| 2026-05-26 | 170.01% | 57.08% | N/A | $26.81 |
| 2026-05-25 | 170.01% | 57.08% | N/A | $26.79 |
| 2026-05-24 | 170.01% | 57.08% | N/A | $26.79 |
| 2026-05-21 | 170.01% | 57.08% | N/A | $26.77 |
| 2026-05-20 | 170.01% | 57.08% | N/A | $26.81 |
| 2026-05-19 | 170.01% | 57.08% | N/A | $26.77 |
| 2026-05-18 | 170.01% | 57.08% | N/A | $26.76 |
| 2026-05-17 | 170.01% | 57.08% | N/A | $26.73 |
| 2026-05-14 | 170.20% | 56.96% | N/A | $26.76 |
| 2026-05-13 | 170.20% | 56.96% | N/A | $26.83 |
| 2026-05-12 | 170.20% | 56.96% | N/A | $26.73 |
| 2026-05-11 | 170.20% | 56.96% | N/A | $26.71 |
| 2026-05-10 | 170.20% | 56.96% | N/A | $26.73 |
| 2026-05-07 | 170.20% | 56.96% | N/A | $26.72 |
| 2026-05-06 | 170.20% | 56.96% | N/A | $26.72 |
| 2026-05-05 | 170.20% | 56.96% | N/A | $26.71 |
| 2026-05-04 | 170.20% | 56.96% | N/A | $26.66 |
| 2026-05-03 | 170.20% | 56.96% | N/A | $26.65 |
| 2026-04-30 | 170.20% | 56.96% | N/A | $26.66 |
| 2026-04-29 | 173.03% | 57.39% | N/A | $26.67 |
| 2026-04-28 | 165.07% | 63.98% | N/A | $19.24 |
| 2026-04-27 | 165.07% | 63.98% | N/A | $19.16 |
| 2026-04-26 | 165.07% | 63.98% | N/A | $19.63 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is KalVista Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-04, KalVista Pharmaceuticals Inc (KALV) has a next-year EPS growth estimate of 170.01%, based on analyst consensus.
When was the latest EPS estimate revision for KALV?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 170.20% to 170.01%.
What sector and industry does KalVista Pharmaceuticals Inc belong to?▾
KalVista Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KALV appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. KalVista Pharmaceuticals Inc (KALV) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports